Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine

NCT00128011 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Cholera

Interventions

BIOLOGICAL: killed oral cholera vaccine

Sponsor

International Vaccine Institute

Collaborators

[object Object]
[object Object]